Skip to content

Abnormal Circulating Lipoprotein A Concentration C5936894

Published: July 22, 2026Updated: August 20, 2026

Lipoprotein(a) is a particle that carries cholesterol in blood. High levels may raise heart disease risk. Doctors monitor levels and recommend heart-healthy habits.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Chest pain

Chest discomfort or pain that may occur with activity or rest, often described as pressure, squeezing, or tightness in the chest.

Seek immediate emergency care if chest pain is severe, prolonged, or accompanied by shortness of breath, sweating, or pain radiating to the arm, jaw, or neck.

!

Sudden weakness or numbness

Sudden onset of weakness, numbness, or paralysis on one side of the body, often indicating a stroke.

This is a medical emergency. Call emergency services immediately if you experience sudden weakness, numbness, confusion, difficulty speaking, or loss of balance.

Shortness of breath

(cardiovascular)

Difficulty breathing or feeling breathless, especially during physical activity or when lying flat.

Frequency: 50-60% of patients with heart involvement

Fatigue

(cardiovascular)

Persistent tiredness or lack of energy that interferes with daily activities, often disproportionate to activity level.

Frequency: 40-50% of patients

Heart palpitations

(cardiovascular)

Awareness of rapid, fluttering, or pounding heartbeats, sometimes felt in the chest or neck.

Frequency: 20-30% of patients

Leg pain when walking

(cardiovascular)

Cramping, pain, or discomfort in the legs during walking or exercise that typically improves with rest (claudication).

Frequency: 15-25% of patients with peripheral artery disease

Swelling in legs

(cardiovascular)

Fluid retention causing swelling (edema) in the lower legs, ankles, or feet.

Frequency: 20-30% of patients with heart involvement

Xanthomas

(cardiovascular)

Yellowish deposits of fat under the skin, typically around tendons, caused by severely elevated lipid levels.

Frequency: Less than 5% of patients with genetic forms

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiovascular risk stratification and monitoring

Comprehensive assessment of overall cardiovascular risk considering elevated lipoprotein(a) as an independent risk factor, with regular monitoring of disease progression and intervention response.

monitoring
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Aggressive cardiovascular risk factor management

Intensive control of all modifiable risk factors including blood pressure, smoking, and weight to compensate for elevated lipoprotein(a)-associated cardiovascular risk.

lifestyle

Additional treatment options

Lipoprotein(a)-lowering pharmacotherapy

Niacin or PCSK9 inhibitors may be considered to modestly reduce lipoprotein(a) concentrations, though response is variable and treatment focuses primarily on risk reduction.

medication

Lipoprotein apheresis

Chronic LDL/Lp(a) apheresis for selected patients with very high lipoprotein(a) concentrations and established cardiovascular disease, providing mechanical removal of atherogenic particles.

procedure

Cardioprotective dietary pattern

Anti-inflammatory dietary approach rich in fruits, vegetables, whole grains, and omega-3 fatty acids to support overall vascular health despite persistent elevated lipoprotein(a) concentrations.

dietary

Medication Comparisons

Compare medications used to treat Abnormal Circulating Lipoprotein A Concentration C5936894. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy